Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-22-025414)

Filing Details

Accession Number:: 0001209191-22-025414
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-04-22 17:00:51
Reporting Period:: 2022-04-20

Accepted Time:: 2022-04-22 17:00:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1501756	Adverum Biotechnologies Inc.	ADVM	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1379344	Laurent Fischer	C/O Adverum Biotechnologies, Inc. 800 Saginaw Drive Redwood City CA 94063	Ceo, President And Director	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-04-20	25,000	$1.11	762,462	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $1.10 to $1.14. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.